Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix
Malvern Panalytical, a company providing advanced analysis and services solutions ...
Creoptix launches new way of measuring kinetics to accelerate drug discovery
Creoptix, a Switzerland-based company focused on next-generation bioanalytical instruments, has ...
Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform
Wädenswil/Zurich, Switzerland and Saffron Walden, UK, 12th January 2021 / Sciad Newswire / Domainex Ltd., ...
Swiss start-ups drive research around Covid-19
Not every Swiss start-up involved in Covid-19 research is developing ...
Microfluidics mastery earns Switzerland’s Creoptix $8m Series C
Spare a thought for agri-tech companies out there focused on ...